scholarly journals Pharmacoeconomic analysis of eviplera (rilpivirine/ tenofovir/ emtricitabine) in the treatment of hiv/aids in the Russian Federation

2015 ◽  
Vol 3 (1) ◽  
pp. 44-51
Author(s):  
A.Yu. Kulikov ◽  
V.V. Babiy
Keyword(s):  
Russian Federation ◽  
Pharmacoeconomic Analysis ◽  
The Russian Federation ◽  
Hiv Aids

scholarly journals Socio-economic monitoring of HIV/AIDS threat in the Russian Federation

2012 ◽  
pp. 153-169 ◽  
Author(s):  
V. A. Chereshnev ◽  
D. N. Verzilin ◽  
T. G. Maхimova ◽  
E. V. Chereshneva
Keyword(s):  
Russian Federation ◽  
The Russian Federation ◽  
Hiv Aids

scholarly journals EVALUATION OF THE CLINICAL AND ECONOMIC EFFECTIVENESS OF INTERFERON-GAMMA IN THE TREATMENT OF TUBERCULOSIS

2017 ◽  
Vol 22 (6) ◽  
pp. 276-280
Author(s):  
S. L Plavinskiy ◽  
Pavel I. Shabalkin
Keyword(s):  
Quality Of Life ◽  
Drug Resistance ◽  
Economic Evaluation ◽  
Health System ◽  
Interferon Gamma ◽  
Russian Federation ◽  
Pharmacoeconomic Analysis ◽  
Treatment Regimens ◽  
The Russian Federation

Tuberculosis worldwide is a serious problem for the health system and for society. Despite the fact that in recent years there has been a tendency to the decline in the incidence of tuberculosis, it remains to be one of the socially significant infections in the Russian Federation. Significant difficulties in the treatment of tuberculosis include the overcoming of the drug resistance of mycobacteria to the existing therapy, as well as the available limitations of the resources of the healthcare system in the Russian Federation. In this regard, there is a need to find additional opportunities to improve the effectiveness of the treatment and clinical and economic evaluation of existing treatment regimens. Interferon-gamma is an effective preparation for the management of tuberculosis. As a result of the pharmacoeconomic analysis, the administration of interferon-gamma (Ingaron) contributed to an increase in the quality of life by 2.1 QALY, and in terms of an addition to the therapy will be accompanied by savings of the budget of the Russian Federation up to 284 million rubles, or up to 27.3% of funds for the treatment of patients from this group.

scholarly journals A Geospatial Bibliometric Review of the HIV/AIDS Epidemic in the Russian Federation

2020 ◽  
Vol 8 ◽  
Author(s):  
Megan E. Gray Neils ◽  
Herman O. I. Pfaeffle ◽  
Art T. Kulatti ◽  
Alena Titova ◽  
Galina S. Lyles ◽  
...  
Keyword(s):  
Russian Federation ◽  
Aids Epidemic ◽  
Bibliometric Review ◽  
The Russian Federation ◽  
Hiv Aids
Sign in / Sign up

Export Citation Format

Share Document